The Pharma Letter1h
FDA nod for Tremfya as J&J builds on Stelara transition
US pharma major Johnson & Johnson (NYSE: JNJ) has won US approval for Tremfya (guselkumab) in the treatment of adults with ...
Urgent warning to all pet owners who let their dogs lick them – after dad of two, 49, dies
PET owners have been warned of the deadly consequences of letting their pets lick them after a dad-of-two tragically died.
Medical Dialogues21h
Psoriasis Patients at Higher Risk of Metabolic and Cardiovascular Conditions, Study Shows
The researchers highlighted that psoriasis is a systemic condition linked to various comorbidities, emphasizing the ...
Clinical Advisor21h
How Does COVID-19 Affect Adults With Atopic Dermatitis, Psoriasis, or Vitiligo?
Researchers studied the relationship between 3 dermatological immune-mediated inflammatory diseases and COVID-19.
Medscape22h
Anti–IL-23 Therapy Might Emerge as Best Biologic in Psoriasis if Used Early and at High Doses
In the treatment of psoriasis, preliminary evidence supports the hypothesis that IL-23 inhibitors are capable of extended remissions and protection against PsA relative to other biologics.
'I'm a doctor - there's a common cause of acne and eczema many don't realise'
A doctor has revealed why you may experience flare ups of acne and eczema all of a sudden - and the answer is more common ...